Request Discount

Cystic Fibrosis (CF) Market (Drug Class - CFTR Modulators, Mucolytic, Pancreatic Enzyme Supplements, Bronchodilators, and Other Drug Classes; Route of Administration - Inhaled Drugs, and Oral Drugs): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : May, 2019

  • Rep Id : HC0491

  • Category : Healthcare & Medical Devices

  • Status : Published

This report provides exclusive insights into the COVID-19 impact on the Cystic Fibrosis. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Cystic Fibrosis. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Cystic Fibrosis. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.

A recent report published by Infinium Global Research on cystic fibrosis (CF) market provides in-depth analysis of segments and sub-segments in the global as well as regional cystic fibrosis market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional cystic fibrosis market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global cystic fibrosis market. According to the report, the global cystic fibrosis market is projected to grow at a CAGR of 16.6% over the forecast period of 2019-2025.


Market Insight

Cystic fibrosis is a genetic disease that mainly affects the lung and digestive systems. The body produces thick and sticky mucus that clog the lungs and obstruct the pancreas. The mucus is difficult to cough out of the lungs and can make breathing difficult. The growing prevalence of cystic fibrosis disease drives the growth of the cystic fibrosis market. Cystic fibrosis is an inherited disorder that causes severe damage to the lungs, digestive system, and other organs in the body. People with cystic fibrosis, a defective gene causes the secretions to become sticky and thick. Instead of acting as a lubricant, the secretions plug up tubes, ducts, and passageways, especially in the lungs and pancreas. Improvements in screening and treatments are the major factors contribute to the growth of the cystic fibrosis therapeutics market. Due to improvements in screening and treatments, mean people with cystic fibrosis now may live into their mid to the late 30s, on average, and some are living into their 40s and 50s.


However, complicated pathophysiology, high cost of treatment and an increase in genetic mutation rate are some of the factors expected to hinder the growth of this market. Furthermore, owing to continued extensive research and development activities, varieties of medicines are expected to launch in the market in the future period. Increasing global awareness for cystic fibrosis therapy, technological advancements in the R&D is expected to provide beneficial opportunities for the cystic fibrosis market.


Among the Geographies, North America held the largest market share in 2017, owing to improve healthcare infrastructure and healthcare policies. The U.S drives the North America market, owing to an early screening of newborns for cystic fibrosis in every state in the United States so that this condition can be diagnosed within the first month of the life before symptoms develop. The European market is considered as the most lucrative market for CF Therapeutics, followed by the North American Market.


Cystic Fibrosis Market

Segment Covered

The report on global cystic fibrosis market covers segments such as drug class and route of administration. On the basis of drug class, the sub-markets include CFTR modulators, mucolytic, pancreatic enzyme supplements, bronchodilators, and other drug classes. On the basis of route of administration, the sub-markets include inhaled drugs and oral drugs.


Companies Profiled:

The report provides profiles of the companies in the market such as Alcresta Therapeutics, Inc., AstraZeneca plc, Teva Pharmaceutical Industries, Allergan plc, Advanced Inhalation Therapies (AIT) Ltd., F. Hoffmann-La Roche AG, Novartis International AG, Gilead Sciences, Inc., Vertex Pharmaceuticals, Inc., AbbVie Inc., and Other Companies.


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the cystic fibrosis market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount